Belgian consensus for Helicobacter pylori management 2023

R Garcés-Duran, S Kindt, K Kotilea, S François, G Rasschaert, A Smet, B Hauser, A Driessen, M Nkuize, A Burette, V Lamy, P Bontems, Hubert Louis, R Ntounda, V Y Miendje Deyi, F Mana

Onderzoeksoutput: Articlepeer review

2 Citaten (Scopus)
8 Downloads (Pure)


Helicobacter pylori (H. pylori) infection causes
chronic gastritis, peptic ulcers and gastric cancer.
Although H. pylori prevalence is decreasing worldwide,
regional variations exist in Europe, with the lowest
infection prevalence in Northern Europe, and the highest
in Eastern and Southern Europe (1). Changes in the
treatment recommendations and the increasing available
evidence have justified the implementation of new
recommendations since last Belgian consensus in 1998
(2). Several non-H. pylori Helicobacter species (NH.
PYLORI-H), colonizing the stomach of domestic animals,
also have the ability to cause gastric disease in humans,
although to a lesser extent. These zoonotic NH. PYLORIH
are not the subject of the current recommendations
Originele taal-2English
Pagina's (van-tot)74-91
Aantal pagina's18
TijdschriftActa Gastro-Enterologica Belgica
Nummer van het tijdschrift1
StatusPublished - jan 2023

Bibliografische nota

This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine


Duik in de onderzoeksthema's van 'Belgian consensus for Helicobacter pylori management 2023'. Samen vormen ze een unieke vingerafdruk.

Citeer dit